Östlund, C., Hernandez-Ono, A., Turk, S. J., Dauer, W. T., Ginsberg, H. N., Worman, H. J., & Shin, J.-Y. (2022). Hepatocytes Deficient in Nuclear Envelope Protein Lamina-associated Polypeptide 1 are an Ideal Mammalian System to Study Intranuclear Lipid Droplets. Journal of Lipid Research, 63(10), 100277. https://doi.org/10.1016/j.jlr.2022.100277

Huang, H., Fang, Y., Jiang, M., Zhang, Y., Biermann, J., Melms, J. C., Danielsson, J. A., Yang, Y., Qiang, L., Liu, J., Zhou, Y., Wang, M., Hu, Z., Wang, T. C., Saqi, A., Sun, J., Matsumoto, I., Cardoso, W. V., Emala, C. W., … Que, J. (2022). Contribution of Trp63CreERT2-labeled cells to alveolar regeneration is independent of tuft cells. ELife, 11. CLOCKSS. https://doi.org/10.7554/elife.78217

Mohajir, W. A., O’keefe, S. J., & Seres, D. S. (2022). Parenteral Nutrition. Medical Clinics of North America, 106(5), e17–e27. https://doi.org/10.1016/j.mcna.2022.07.002

Toth, P. P., Schwartz, G. G., Nicholls, S. J., Khan, A., Szarek, M., Ginsberg, H. N., Johansson, J. O., Kalantar-Zadeh, K., Kulikowski, E., Lebioda, K., Wong, N. C. W., Sweeney, M., & Ray, K. K. (2022). Reduction in the risk of major adverse cardiovascular events with the BET protein inhibitor apabetalone in patients with recent acute coronary syndrome, type 2 diabetes, and moderate to high likelihood of non-alcoholic fatty liver disease. American Journal of Preventive Cardiology, 11, 100372. https://doi.org/10.1016/j.ajpc.2022.100372

Mohajir, W. A., O’keefe, S. J., & Seres, D. S. (2022). Disease-Related Malnutrition and Enteral Nutrition. Medical Clinics of North America, 106(5), e1–e16. https://doi.org/10.1016/j.mcna.2022.10.002

Kim, K., Ginsberg, H. N., & Choi, S. H. (2022). New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins. Diabetes & Metabolism Journal, 46(4), 517–532. https://doi.org/10.4093/dmj.2022.0198

Zahr, T., Sun, K., & Qiang, L. (2022). The polarizable and reprogrammable identity of Kupffer cells in Nonalcoholic Steatohepatitis. Medical Review, 2(4), 324–327. https://doi.org/10.1515/mr-2022-0023

Emiliano, A. B., Lopatinsky, N. R., Kraljević, M., Higuchi, S., He, Y., Haeusler, R. A., & Schwartz, G. J. (2022). Sex-specific differences in metabolic outcomes after sleeve gastrectomy and intermittent fasting in obese middle-aged mice. American Journal of Physiology-Endocrinology and Metabolism, 323(1), E107–E121. https://doi.org/10.1152/ajpendo.00017.2022

Rahaman, S. M., Chowdhury, S., Mukai, Y., Ono, D., Yamaguchi, H., & Yamanaka, A. (2022). Functional Interaction Between GABAergic Neurons in the Ventral Tegmental Area and Serotonergic Neurons in the Dorsal Raphe Nucleus. Frontiers in Neuroscience, 16. https://doi.org/10.3389/fnins.2022.877054

Solberg, N., Yuan, H., Varghese, A., Tarar, K., LaForest, M., & Seres, D. (2022). A Qualitative Systematic Review of Risk Factors for Refeeding Syndrome. Current Developments in Nutrition, 6, 753. https://doi.org/10.1093/cdn/nzac062.022

Huang, J., Cao, H., Shea, S., Chan, C., Zeevi, A., & Seres, D. (2022). Preliminary Analysis for Development of AI to Identify Hospitalized Patients for Whom Nourishment Will Provide Benefit. Current Developments in Nutrition, 6, 743. https://doi.org/10.1093/cdn/nzac062.012

Adams, S. C., Gura, K. M., Seres, D. S., Kovacevich, D., Maguire, A., Herlitz, J., Canada, T. W., Nishikawa, R., & Boullata, J. (2022). Safe care transitions for patients receiving parenteral nutrition. Nutrition in Clinical Practice, 37(3), 493–508. Portico. https://doi.org/10.1002/ncp.10861

Qian, Y., Qian, X., Shen, M., Vu, A., & Seres, D. S. (2022). Effect of malnutrition on outcomes in patients with heart failure: A large retrospective propensity score–matched cohort study. Nutrition in Clinical Practice, 37(1), 130–136. Portico. https://doi.org/10.1002/ncp.10815

Bowman, C. A., Hutchins, E., Burgermaster, M., Sant, V., & Seres, D. S. (2022). Nasal Feeding Tubes Are Associated with Fewer Adverse Events than Feeding via Ostomy in Hospitalized Patients Receiving Enteral Nutrition. The American Journal of Medicine, 135(1), 97-102.e1. https://doi.org/10.1016/j.amjmed.2021.08.020

Ginsberg, H. N., Packard, C. J., Chapman, M. J., Borén, J., Aguilar-Salinas, C. A., Averna, M., Ference, B. A., Gaudet, D., Hegele, R. A., Kersten, S., Lewis, G. F., Lichtenstein, A. H., Moulin, P., Nordestgaard, B. G., Remaley, A. T., Staels, B., Stroes, E. S. G., Taskinen, M.-R., Tokgözoğlu, L. S., … Catapano, A. L. (2021). Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society. European Heart Journal, 42(47), 4791–4806. https://doi.org/10.1093/eurheartj/ehab551

Schwartz, G. G., Nicholls, S. J., Toth, P. P., Sweeney, M., Halliday, C., Johansson, J. O., Wong, N. C. W., Kulikowski, E., Kalantar-Zadeh, K., Ginsberg, H. N., & Ray, K. K. (2021). Relation of insulin treatment for type 2 diabetes to the risk of major adverse cardiovascular events after acute coronary syndrome: an analysis of the BETonMACE randomized clinical trial. Cardiovascular Diabetology, 20(1). https://doi.org/10.1186/s12933-021-01311-9

Lund, S. S., Sattar, N., Salsali, A., Neubacher, D., & Ginsberg, H. N. (2021). Potential contribution of haemoconcentration to changes in lipid variables with empagliflozin in patients with type 2 diabetes: A post hoc analysis of pooled data from four phase 3 randomized clinical trials. Diabetes, Obesity and Metabolism, 23(12), 2763–2774. Portico. https://doi.org/10.1111/dom.14534